Showing results (991-1000 of 1,292) with videos related to

Sort By:
Pageof 130
Veterinary and Comparative Oncology|January 13, 2012
Bisphosphonates significantly increase the activity of doxorubicin or vincristine against canine malignant histiocytosis cellsS D Hafeman, D Varland, S W Dow
Veterinary and Comparative Oncology|January 13, 2012
Elevated serum thymidine kinase activity in canine splenic hemangiosarcoma*D H Thamm, D A Kamstock, C R Sharp, et al.
Veterinary and Comparative Oncology|January 13, 2012
Fascin-1 expression in canine cutaneous and oral melanocytic tumoursN Yamada, T Mori, M Murakami, et al.
Veterinary and Comparative Oncology|September 26, 2021
Extensive staging has no prognostic value in dogs with low-risk mast cell tumoursCsilla Fejös, Karin Troedson, Nataliia Ignatenko, et al.
Veterinary and Comparative Oncology|June 19, 2019
Limb-sparing in dogs using patient-specific, three-dimensional-printed endoprosthesis for distal radial osteosarcoma: A pilot studyBernard Séguin, Chris Pinard, Bertrand Lussier, et al.
Veterinary and Comparative Oncology|May 18, 2019
Influence of E-cadherin genetic variation in canine mammary tumour risk, clinicopathological features and prognosisAna Canadas, Marta Santos, Rui Medeiros, et al.
Veterinary and Comparative Oncology|May 22, 2019
In vitro effects of the activity of novel platinum (II) complex in canine and human cell linesMarta Henklewska, Aleksandra Pawlak, Justyna Kutkowska, et al.
Veterinary and Comparative Oncology|April 20, 2022
Evaluation of the anti-tumour activity of Coriolus versicolor polysaccharopeptide (I'm-Yunity) alone or in combination with doxorubicin for canine splenic hemangiosarcomaAllison Gedney, Pascale Salah, Jennifer A Mahoney, et al.
Veterinary and Comparative Oncology|March 27, 2022
Anticancer activity of IRAK-4 inhibitors against canine lymphoid malignanciesJun-Hyeong Park, Jeong-Hwa Lee, Ju-Hyun An, et al.
Veterinary and Comparative Oncology|March 26, 2022
A retrospective study of 101 dogs with oral melanoma treated with a weekly or biweekly 6 Gy × 6 radiotherapy protocolAlexie J Baja, Krista L Kelsey, David M Ruslander, et al.
Pageof 130